Black Rock Inc. Tyme Technologies, Inc. Transaction History

Black Rock Inc.

  • $4.35 Trillion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.0 - $0.35 $0 - $674,821
-1,928,061 Closed
0 $0
Q2 2022

Aug 12, 2022
SELL
$0.23 - $0.35 $33,949 - $51,661
-147,605 Reduced 7.11%
1,928,061 $540,000
Q1 2022

May 12, 2022
SELL
$0.28 - $0.68 $1,260 - $3,060
-4,500 Reduced 0.22%
2,075,666 $726,000
Q4 2021

Feb 10, 2022
SELL
$0.6 - $1.04 $2,718 - $4,711
-4,530 Reduced 0.22%
2,080,166 $1.25 Million
Q3 2021

Nov 09, 2021
BUY
$0.99 - $1.38 $165,220 - $230,306
166,889 Added 8.7%
2,084,696 $2.15 Million
Q2 2021

Aug 11, 2021
BUY
$1.14 - $1.87 $2.19 Million - $3.59 Million
1,917,807 New
1,917,807 $2.42 Million

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email